Avastin challenges Lucentis dominance in wet AMD - Cameron Optometry | Cameron Optometry
Avastin challenges Lucentis dominance in wet AMD

Avastin challenges Lucentis dominance in wet AMD

Posted on 26th April 2012

The leading wet AMD treatment used in the NHS, Lucentis, is under pressure from a cheaper version called Avastin.

Both compounds are from the family of AntiVEGF drugs (anti-vascular endothelial growth factor). In wet AMD, the degeneration causes the retina to make tiny new blood vessels in response to damage. These blood vessels are very fragile and break and bleed into the retina causing scarring and eventually vision loss.

AntiVEGF drugs stop and even shrink the growth of these new blood vessels preventing the damaging bleeding. Until now Lucentis has been the only approved drug for use in the eye and costs over £700 per injection (used in multiples of 3 injections normally). Avastin is in the same family of drugs and currently used to treat heart conditions. Costing only £60 per injection, many specialists in other countries have been using it ‘off label’ in the eye to great effect.

Avastin is now being used to treat 50% of AMD cases in the US and there is increasing pressure on the NHS to approve the use of this drug enabling far more access to the sight saving treatment.

At Cameron Optometry, we’re experts in all forms of macular disease and have the latest OCT technology which is used by specialists to diagnose and monitor the effects of treatment on wet AMD. If you are concerned or have a family history of the condition, come and see us for some expert advice.


Related Posts

Back to school eye examination

16th August 2018

We hope the start of the new term is going well for all who went back this week. Did you manage to get your child's eyes examined over the holidays? Children should have their eyes examined by an opto...

Read more

Win New Glasses For The New Term

31st July 2018

New uniform. New shoes. New pencil case. New bag. What about some new glasses to make sure your child looks super smart when they go back to school? We are offering your child, the chance to win their...

Read more

Gillian Bruce completes masters as top performing student

18th June 2018

We’re thrilled to announce that our clinical lead optometrist, Gillian Bruce, has passed her Masters of Science (MSc) degree in Primary Care Ophthalmology with distinction. As if that wasn’t impre...

Read more

Update: Our successful Myopia Management programme

24th May 2018

When we first wrote in our blog about Myopia Management over two years ago, it was all quite new. Cameron Optometry was one of the first optometrists in the UK to set up a Myopia Management programme ...

Read more